United Therapeutics Corp. (UTHR)
468.66
+0.59
(+0.13%)
USD |
NASDAQ |
Jan 21, 14:12
United Therapeutics Shareholders Equity (Quarterly): 6.590B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 631.90M |
| Gilead Sciences, Inc. | 21.54B |
| Johnson & Johnson | 79.28B |
| Catalyst Pharmaceuticals, Inc. | 920.24M |
| Plus Therapeutics, Inc. | 5.054M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.351B |
| Total Liabilities (Quarterly) | 760.90M |
| Current Ratio | 6.396 |
| Net Debt Paydown Yield | 0.56% |